Eventide Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.7M | Sell |
728,437
-124,408
| -15% | -$2.68M | 0.28% | 107 |
|
|
2025
Q1 | $14.2M | Hold |
852,845
| – | – | 0.28% | 105 |
|
|
2024
Q4 | $15.6M | Buy |
852,845
+275,345
| +48% | +$5.05M | 0.29% | 109 |
|
|
2024
Q3 | $8.88M | Buy |
+577,500
| New | +$8.88M | 0.15% | 125 |
|
|
2024
Q1 | – | Sell |
-809,391
| Closed | -$25.3M | – | 157 |
|
|
2023
Q4 | $25.3M | Buy |
+809,391
| New | +$25.3M | 0.41% | 75 |
|
|
2018
Q3 | – | Sell |
-113,600
| Closed | -$1.74M | – | 146 |
|
|
2018
Q2 | $1.74M | Hold |
113,600
| – | – | 0.07% | 118 |
|
|
2018
Q1 | $2.55M | Sell |
113,600
-221,100
| -66% | -$4.97M | 0.12% | 103 |
|
|
2017
Q4 | $10.1M | Hold |
334,700
| – | – | 0.53% | 60 |
|
|
2017
Q3 | $12.6M | Hold |
334,700
| – | – | 0.71% | 53 |
|
|
2017
Q2 | $9.34M | Hold |
334,700
| – | – | 0.58% | 51 |
|
|
2017
Q1 | $11.5M | Hold |
334,700
| – | – | 0.76% | 47 |
|
|
2016
Q4 | $9.65M | Hold |
334,700
| – | – | 0.63% | 51 |
|
|
2016
Q3 | $10.6M | Hold |
334,700
| – | – | 0.65% | 49 |
|
|
2016
Q2 | $10.9M | Hold |
334,700
| – | – | 0.66% | 52 |
|
|
2016
Q1 | $9.36M | Hold |
334,700
| – | – | 0.52% | 56 |
|
|
2015
Q4 | $11.9M | Buy |
334,700
+8,000
| +2% | +$285K | 0.6% | 55 |
|
|
2015
Q3 | $10.8M | Buy |
326,700
+55,600
| +21% | +$1.84M | 0.63% | 49 |
|
|
2015
Q2 | $11.4M | Hold |
271,100
| – | – | 0.61% | 54 |
|
|
2015
Q1 | $8.84M | Sell |
271,100
-152,100
| -36% | -$4.96M | 0.66% | 57 |
|
|
2014
Q4 | $13.4M | Hold |
423,200
| – | – | 1.47% | 24 |
|
|
2014
Q3 | $10.5M | Hold |
423,200
| – | – | 1.46% | 27 |
|
|
2014
Q2 | $9.56M | Buy |
423,200
+229,700
| +119% | +$5.19M | 1.3% | 33 |
|
|
2014
Q1 | $4.71M | Buy |
193,500
+18,100
| +10% | +$440K | 0.73% | 55 |
|
|
2013
Q4 | $4.38M | Buy |
+175,400
| New | +$4.38M | 1.35% | 40 |
|